Is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) Halal?

NASDAQ Healthcare United States $381M
✗ NOT HALAL
Confidence: 90/100
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 168.5% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 168.5%
/ 30%
67.1%
/ 30%
8.5%
/ 30%
11.54%
/ 5%
✗ NOT HALAL
DJIM 168.5%
/ 33%
67.1%
/ 33%
8.5%
/ 33%
11.54%
/ 5%
✗ NOT HALAL
MSCI 89.6%
/ 33%
35.6%
/ 33%
4.5%
/ 33%
11.54%
/ 5%
✗ NOT HALAL
S&P 168.5%
/ 33%
67.1%
/ 33%
8.5%
/ 33%
11.54%
/ 5%
✗ NOT HALAL
FTSE 89.6%
/ 33%
35.6%
/ 33%
4.5%
/ 50%
11.54%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-1.82
P/B Ratio
70.0
EV/EBITDA
-4.7
EV: $803M
Revenue
$160M
Growth: 13.8%
Beta
2.3
High volatility
Current Ratio
5.2

Profitability

Gross Margin 34.3%
Operating Margin -134.5%
Net Margin 0.0%
Return on Equity (ROE) -213.5%
Return on Assets (ROA) -33.7%

Cash Flow & Balance Sheet

Operating Cash Flow-$111M
Free Cash Flow-$119M
Total Debt$702M
Debt-to-Equity13131.8
Current Ratio5.2
Total Assets$784M

Price & Trading

Last Close$1.35
50-Day MA$1.76
200-Day MA$1.66
Avg Volume7.0M
Beta2.3
52-Week Range
$0.85
$2.73

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

CEO
Mr. Christian O. Henry M.B.A.
Employees
485
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$381M
Currency
USD

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company provides Revio, Vega, and Sequel instruments which conduct, monitor, and analyze single-molecule biochemical reactions on SMRT cell microchips; short-read sequencing; and onso instrument. It serves academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations, pharmaceutical companies, and agricultural companies. The company markets its products through a sales force and distribution partners in Australia, certain parts of Asia, Europe, the Middle East, Africa, Central America, and South America. It has a collaboration with DNAstack Inc. to provide federated dataset of HiFi whole genome sequencing data. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s debt ratio?

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s debt ratio is 168.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 89.6%.

What are PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s key financial metrics?

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. has a market capitalization of $381M, and revenue of $160M. Return on equity stands at -213.5%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.